Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products. An article discussing this reads: “Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market that’s projected to reach $135 billion by 2021 (http://cnw.fm/ud2WJ). SKVI also sees a worldwide dermatology market of $80 billion, plus a $30 billion worldwide over-the-counter (OTC) market (http://cnw.fm/noE7Y). It has already completed the development of 40 products, received numerous technology and product patents and is now ready to monetize its investment. In the U.S. alone, skincare is projected to reach $10.7 billion by 2018, and the global skincare market is seen growing at a compound annual growth rate (CAGR) of 3.8% from 2016-2021, according to MarketResearch.com (http://cnw.fm/Ad62P).”
To view the full article, visit http://cnw.fm/ewo8M
About Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. For more information, visit www.skinvisible.com or www.invisicare.com.
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com